george hasko
george hasko
E-mail megerősítve itt: cumc.columbia.edu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
G Haskó, BN Cronstein
CRC, 2007
10152007
Adenosine: an endogenous regulator of innate immunity
G Haskó, BN Cronstein
Trends in immunology 25 (1), 33-39, 2004
8562004
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
OV Evgenov, P Pacher, PM Schmidt, G Haskó, HHHW Schmidt, JP Stasch
Nature reviews Drug discovery 5 (9), 755-768, 2006
6772006
CD39 and CD73 in immunity and inflammation
L Antonioli, P Pacher, ES Vizi, G Haskó
Trends in molecular medicine 19 (6), 355-367, 2013
5942013
Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.
G Hasko, C Szabó, ZH Németh, V Kvetan, SM Pastores, ES Vizi
The Journal of Immunology 157 (10), 4634-4640, 1996
5451996
Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms
G HASKÓ, DG KUHEL, JFAN CHEN, MA SCHWARZSCHILD, EA DEITCH, ...
The FASEB journal 14 (13), 2065-2074, 2000
5042000
Immunity, inflammation and cancer: a leading role for adenosine
L Antonioli, C Blandizzi, P Pacher, G Haskó
Nature Reviews Cancer 13 (12), 842-857, 2013
4442013
Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy
P Mukhopadhyay, M Rajesh, G Haskó, BJ Hawkins, M Madesh, P Pacher
Nature protocols 2 (9), 2295, 2007
3412007
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
P Mukhopadhyay, M Rajesh, S Bátkai, Y Kashiwaya, G Hasko, L Liaudet, ...
American Journal of Physiology-Heart and Circulatory Physiology 296 (5 …, 2009
3102009
Simple quantitative detection of mitochondrial superoxide production in live cells
P Mukhopadhyay, M Rajesh, K Yoshihiro, G Haskó, P Pacher
Biochemical and biophysical research communications 358 (1), 203-208, 2007
3082007
Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock
G Haskó, DG Kuhel, ZH Németh, JG Mabley, RF Stachlewitz, L Virág, ...
The Journal of Immunology 164 (2), 1013, 2000
2922000
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
M Rajesh, P Mukhopadhyay, S Bátkai, V Patel, K Saito, S Matsumoto, ...
Journal of the American College of Cardiology 56 (25), 2115-2125, 2010
2672010
An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors
G Pinhal-Enfield, M Ramanathan, G Hasko, SN Vogel, AL Salzman, ...
The American journal of pathology 163 (2), 711-721, 2003
2602003
Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury
S Bátkai, D Osei‐Hyiaman, H Pan, O El‐Assal, M Rajesh, ...
The FASEB Journal 21 (8), 1788-1800, 2007
2572007
Immunomodulatory and neuroprotective effects of inosine
G Haskó, MV Sitkovsky, C Szabó
Trends in pharmacological sciences 25 (3), 152-157, 2004
2532004
A2A receptors in inflammation and injury: lessons learned from transgenic animals
G Haskó, P Pacher
Journal of leukocyte biology 83 (3), 447-455, 2008
2452008
CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
M Rajesh, P Mukhopadhyay, S Bátkai, G Haskó, L Liaudet, JW Huffman, ...
American Journal of Physiology-Heart and Circulatory Physiology 293 (4 …, 2007
2452007
Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism
ZH Németh, CS Lutz, B Csóka, EA Deitch, SJ Leibovich, WC Gause, ...
The Journal of Immunology 175 (12), 8260-8270, 2005
2372005
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents*
P Jagtap, FG Soriano, L Virág, L Liaudet, J Mabley, É Szabó, G Haskó, ...
Critical care medicine 30 (5), 1071, 2002
2242002
HIF-1: a key mediator in hypoxia
J Adams, L Difazio, R Rolandelli, J Lujan, GY Hasko, B Csoka, ...
Acta Physiologica Hungarica 96 (1), 19-28, 2009
2212009
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20